FDA expands labeling for SmartLight
Israeli computerized light box developer SmartLight this month got the go-ahead from the Food and Drug Administration for expanded labeling for its products. On June 14, the FDA cleared SmartLight’s claim that, compared with conventional
Israeli computerized light box developer SmartLight this month got the go-ahead from the Food and Drug Administration for expanded labeling for its products. On June 14, the FDA cleared SmartLights claim that, compared with conventional light boxes, the companys motorized system substantially improves clinicians ability to see more detail in films. SmartLight submitted a study of more than 1000 radiologists reading quality control mammography films to back up its 510(k) filing (SCAN 5/26/99).
The FDA also cleared SmartLights claim that its viewing systems can reduce effects of age on the ability of older radiologists to see small, low-contrast objects. According to SmartLight, radiologists aged 45 to 60 viewing x-rays on its light boxes can detect smaller, lower-contrast objects than their 30-year-old colleagues can using conventional light boxes.
© 1999 Miller Freeman, Inc.All rights reserved.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
